You are using an outdated browser. Please upgrade your browser to improve your experience.

Tchem
PHGDH
D-3-phosphoglycerate dehydrogenase

Protein Summary
Description
Catalyzes the reversible oxidation of 3-phospho-D-glycerate to 3-phosphonooxypyruvate, the first step of the phosphorylated L-serine biosynthesis pathway. Also catalyzes the reversible oxidation of 2-hydroxyglutarate to 2-oxoglutarate and the reversible oxidation of (S)-malate to oxaloacetate. This gene encodes the enzyme which is involved in the early steps of L-serine synthesis in animal cells. L-serine is required for D-serine and other amino acid synthesis. The enzyme requires NAD/NADH as a cofactor and forms homotetramers for activity. Mutations in this gene have been found in a family with congenital microcephaly, psychomotor retardation and other symptoms. Multiple alternatively spliced transcript variants have been found, however the full-length nature of most are not known. [provided by RefSeq, Aug 2011]
Uniprot Accession IDs
Gene Name
Ensembl ID
  • ENST00000641023
  • ENSP00000493175
  • ENSG00000092621
  • ENST00000641597
  • ENSP00000493382

Symbol
  • PGDH3
  • NLS
  • PDG
  • PGD
  • NLS1
  • PGAD
  • PGDH
  • SERA
  • 3PGDH
  • 3-PGDH
  • PHGDHD
  • HEL-S-113
Illumination Graph
Knowledge Table
Most Knowledge About
Knowledge Value (0 to 1 scale)
interacting protein
1
protein complex
1
transcription factor perturbation
0.96
disease perturbation
0.93
kinase perturbation
0.93


IDG Development Level Summary
Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 2766.08   (req: < 5)
Gene RIFs: 56   (req: <= 3)
Antibodies: 405   (req: <= 50)
Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 2766.08   (req: >= 5)
Gene RIFs: 56   (req: > 3)
Antibodies: 405   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 17
Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligands: 198
Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0